Comment on

• Persisting corneal erosion under cetuximab (Erbitux) treatment (epidermal growth factor receptor antibody).

  Foerster CG, Cursiefen C, Kruse FE. Foerster CG, et al. Cornea. 2008 Jun;27(5):612-4. doi: 10.1097/ICO.0b013e318166f483. Cornea. 2008. PMID: 18520515
• Intraductal meibomian gland probing relieves symptoms of obstructive meibomian gland dysfunction.

  Maskin SL. Maskin SL. Cornea. 2010 Oct;29(10):1145-52. doi: 10.1097/ICO.0b013e3181d836f3. Cornea. 2010. PMID: 20622668
• Randomized double-blind clinical trial of autologous serum versus artificial tears in dry eye syndrome.

  Urzua CA, Vasquez DH, Huidobro A, Hernandez H, Alfaro J. Urzua CA, et al. Curr Eye Res. 2012 Aug;37(8):684-8. doi: 10.3109/02713683.2012.674609. Epub 2012 Jun 6. Curr Eye Res. 2012. PMID: 22670856 Clinical Trial.
• Intraductal meibomian gland probing in the management of ocular rosacea.

  Wladis EJ. Wladis EJ. Ophthalmic Plast Reconstr Surg. 2012 Nov-Dec;28(6):416-8. doi: 10.1097/IOP.0b013e3182627ebc. Ophthalmic Plast Reconstr Surg. 2012. PMID: 22836802
• Tear osmolarity and ocular changes in pterygium.

  Julio G, Lluch S, Pujol P, Alonso S, Merindano D. Julio G, et al. Cornea. 2012 Dec;31(12):1417-21. doi: 10.1097/ICO.0b013e318259c934. Cornea. 2012. PMID: 22902494
• Is whole-body hydration an important consideration in dry eye?

  Walsh NP, Fortes MB, Raymond-Barker P, Bishop C, Owen J, Tye E, Esmaeelpour M, Purslow C, Elghenzai S. Walsh NP, et al. Invest Ophthalmol Vis Sci. 2012 Sep 25;53(10):6622-7. doi: 10.1167/iovs.12-10175. Invest Ophthalmol Vis Sci. 2012. PMID: 22952120